Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Insights/Evidence synthesis/Assessing publication bias in clinical research

Assessing publication bias in clinical research

The problem begins before the review does: trials that are conducted and never reported make the published record an incomplete account of what was tried.

Bias and critical appraisal

The scale of non-publication

A substantial proportion of clinical trials are never published, and non-publication is associated with results that were null or unfavourable. Trials that are published take longer to appear when the result is negative.

The effect on the evidence base is cumulative: systematic reviews, guidelines and regulatory decisions all draw on a record that is skewed toward benefit.

The structural remedies

Prospective registration. ICMJE member journals require registration in a public registry before the first participant is enrolled, as a condition of considering the paper. Registration makes the existence of a trial a matter of record whether or not it is ever published.

Results reporting requirements. Trial registries provide for summary results to be posted, and several jurisdictions impose reporting obligations with deadlines after completion.

Pre-specified outcomes. Registration also fixes the primary outcome in advance, which is what makes outcome switching detectable — comparing the registered outcome with the published one is a standard check.

What authors and reviewers can do

Authors: register prospectively, publish regardless of result, and report all pre-specified outcomes including those that disappointed. A null result from an adequately powered trial is a finding.

Reviewers and editors: check the registration, compare registered and reported outcomes, and ask about discrepancies. This is one of the few checks that reliably detects a specific and consequential problem.

Review teams: search registries for completed-but-unpublished trials and report what was found but not retrievable.

Why "negative" is the wrong word

A trial that finds no difference has produced information. Calling it negative frames it as a failure and contributes to the decision not to submit it, which is the mechanism that creates the bias in the first place.

In practice

Fix, flag or query.

The distinction that keeps an edit defensible: what an editor may change silently, what must be shown to the author, and what only the author can answer.

  • Register prospectively — ICMJE journals require it before first enrolment.
  • Publish regardless of direction of result.
  • Check: registered primary outcome against the published one.

Sources

  • ICMJE Recommendations, on clinical trial registration
  • ClinicalTrials.gov and WHO ICTRP registry network
  • Cochrane Handbook, on searching registries for unpublished studies

Sources are given so each claim can be checked at its origin. Where a tool’s current maintenance status could not be confirmed, the page says to check it rather than asserting it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.